New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2014
08:35 EDTNPSPNPS Pharmaceuticals receives orphan drug designation for Natpara in Europe
NPS Pharmaceuticals announced that the European Commission has granted orphan drug designation to Natpara for the treatment of hypoparathyroidism. Orphan drug designation in the European Union is given to products that are designed for the diagnosis, prevention or treatment of rare diseases that are life-threatening or chronically debilitating. The company was also granted orphan drug status by the U.S. Food and Drug Administration in 2007. The company submitted its U.S. Biologic License Application to FDA in October 2013.
News For NPSP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 18, 2014
06:33 EDTNPSPNPS Pharmaceuticals coverage resumed with a Neutral at Sterne Agee
Subscribe for More Information
December 17, 2014
11:28 EDTNPSPNPS Pharmaceuticals calls active on Shire considering bid report
Subscribe for More Information
11:13 EDTNPSPShire considering bid for NPS Pharmaceuticals, Bloomberg reports
Subscribe for More Information
10:49 EDTNPSPNPS Pharmaceuticals jumps 12%, halted after report of potential Shire bid
Shire (SHPG) has NPS Pharmaceuticals (NPSP) on the top of its list of potential takeover targets, but is also said to be considering other targets, according to Bloomberg.
10:47 EDTNPSPNPS Pharmaceuticals said to be on top of Shire takeover list, Bloommberg says
Subscribe for More Information
10:47 EDTNPSPNPS halted for volatility after Bloomberg says Shire considers bid
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use